OBSRV — Observe Medical ASA Income Statement
0.000.00%
Last trade - 00:00- NOK16.85m
- NOK101.03m
- NOK18.48m
Annual income statement for Observe Medical ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | PRESS | PRESS |
| Standards: | IFRS | IFRS | IFRS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2.96 | 24 | 19.5 | 27.9 | 18.5 |
| Cost of Revenue | |||||
| Gross Profit | 0.986 | 9.52 | 5.18 | 9.29 | 3.07 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 31 | 60.6 | 78.7 | 80.9 | 131 |
| Operating Profit | -28.1 | -36.5 | -59.1 | -53 | -113 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -36.9 | -26.3 | -50.7 | -63.9 | -127 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -36.9 | -26.3 | -50.8 | -63.9 | -127 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -36.9 | -26.3 | -50.8 | -63.9 | -127 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -36.9 | -26.3 | -50.8 | -63.9 | -127 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -17.4 | -12.8 | -9.99 | -16.6 | -3.75 |
| Dividends per Share |